Abstract
A total of 400 patients with 5 types of allergic conjunctivitis were divided into control and treatment groups (n=200 each). The control group took conventional medication while the treatment group received sublingual immunotherapy (SLIT). After 2-year treatment, for perennial allergic, seasonal allergic or atopic angle conjunctivitis, the decreases of medication score in the treatment group were all significantly more than those in the control group (all P<0.01). No serious adverse event was reported. SLIT with Dermatophagodies farianae drops is both safe and effective in patients with perennial allergic, seasonal allergic and atopic angle conjunctivitis. However its efficacies for vernal and giant papillary conjunctivitis require further studies. Key words: Conjunctivitis, allergic; Immunotherapy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
